Transmissible cancers—malignant cell lineages capable of spreading between individuals—are increasingly recognized as a significant threat to marine and aquatic ecosystems. Research has confirmed that these “contagious cancers” have evolved independently across multiple bivalve species and fish populations, moving beyond the well-known examples of Tasmanian devil facial tumor disease to affect clams, mussels, and bullheads in diverse geographic regions.
The Global Spread of Bivalve Transmissible Neoplasia
Transmissible cancer in marine bivalves, often termed bivalve transmissible neoplasia (BTN), functions similarly to a parasite. According to studies published in Nature and Cell, these cancer cells can survive in seawater and infect new hosts, leading to widespread outbreaks. Investigations into soft-shell clams (Mya arenaria) and various mussel species (Mytilus) have identified distinct, clonal lineages that have crossed species boundaries in the Seas of Southern Europe and the Baltic Sea. Research by Michnowska et al. (2022) in Molecular Ecology highlights that this horizontal transmission of disseminated neoplasia is a persistent issue in the Southern Baltic, while recent findings in PNAS (2026) confirm the detection of BTN in hybridizing soft-shell clam populations in Puget Sound, suggesting a transcontinental reach.
Did you know?
Transmissible cancers are not limited to one species. Genomic sequencing has revealed that some cancer lineages have jumped between different clam species, using the host’s own biology to facilitate their survival and spread.
Melanoma in Brown Bullhead Populations
In freshwater environments, the brown bullhead (Ameiurus nebulosus) serves as an indicator species for environmental health. According to V. S. Studies of the Anacostia River by Sakaris et al. (2005) examined seasonal movement patterns and home ranges of the species. New research published in 2026 by Blazer et al. further refines the understanding of risk factors for these melanistic lesions, emphasizing the need for ongoing surveillance in the northeastern United States and Canada.
Genomic Evolution and Future Surveillance
The ability to track these diseases relies heavily on advancements in genomic pipelines. Tools like GetOrganelle for mitochondrial assembly and Mutect2 for somatic variant calling allow researchers to distinguish between host DNA and the clonal cancer lineage. Scientists are now using these methods to map the evolution of tumors, as seen in the work of Baez-Ortega et al. (2019) regarding ancient transmissible lineages.
FAQ: Understanding Contagious Cancer
- Can these cancers affect humans?
- How do these cancers spread? In bivalves, cancer cells are shed into the water column and enter a new host through filtration. In Tasmanian devils, the transmission occurs through direct physical contact, usually biting.
- Why is the brown bullhead important? Brown bullheads are used as an indicator species for environmental health.
The study of transmissible cancer remains a rapidly evolving field. To stay updated on the latest findings in marine pathology and environmental health, subscribe to our research newsletter or explore our archives on aquatic ecology.
Keep reading
- Alberta Keeps $100 COVID-19 Vaccine Fee Ahead of Fall Flu Campaign
- Social Media Driving Misuse of Alzheimer’s Blood Tests
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)